SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : A US National Health Care System?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: TimF12/13/2022 4:48:03 PM
   of 42652
 
An experimental mRNA cancer-fighting vaccine jointly developed by Moderna and Merck has reportedly succeeded in a Phase II trial. According to the companies, melanoma survivors who received the vaccine in combination with immunotherapy were 44% less likely to have their cancer return or to die than those who only took the immunotherapy. The findings indicate that mRNA vaccines could be an effective tool against cancer and will pave the way for larger, Phase III trials of the treatment.
gizmodo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext